Study of Myfortic in Combination With Tacrolimus and Thymoglobulin in Early Corticosteroid Withdrawal

Inclusion Criteria: * Males and females between 18 and 75 years of age. * Patients who are primary or repeat cadaveric, living unrelated or non-HLA identical living related donor renal transplant recipients. Exclusion Criteria: * Patient previously received or is receiving an organ transplant other than kidney. * Primary or re-transplant from human leukocyte antigen (HLA)-identical living donor. * Recipient or donor is known to be seropositive for hepatitis C virus (HCV), hepatitis B virus (HBV), or human immunodeficiency virus (HIV). * Uncontrolled concomitant infection or other unstable medical condition. * Patients that received an investigational drug in the 30 days prior to transplant. * Known hypersensitivity to tacrolimus, mycophenolate mofetil (MMF), enteric-coated mycophenolic acid, rabbit anti-thymocyte globulin, or corticosteroids. * Receiving chronic steroid therapy at the time of transplant. * History of malignancy in last 5 years. * Pregnant or lactating.